1. Executive Summary |
2. Global Opioids Addiction Prevention Market Introduction |
2.1. Global Opioids Addiction Prevention Market – Taxonomy |
2.2. Global Opioids Addiction Prevention Market –Definitions |
2.2.1. Drug Type |
2.2.2. Treatment Centers |
2.2.3. Route of Administration |
2.2.4. Distribution Channel |
2.2.5. Region |
3. Global Opioids Addiction Prevention Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Opioids Addiction Prevention Market Dynamic Factors - Impact Analysis |
3.6. Impact of COVID 19 on The Market |
3.7. Three Forecast Scenarios - Pessimistic, Conservative and Opportunistic |
3.8. Mapping Market Players Activities |
3.9. Recent Key Developments |
3.10. Financial Status of the Market Players |
3.11. Recent Acquisitions, Collaborations and Mergers |
4. Global Opioids Addiction Prevention Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Opioids Addiction Prevention Market Forecast, By Drug Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1. Naloxone |
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Buprenorphine |
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Methadone |
5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Opioids Addiction Prevention Market Forecast, By Treatment Centers, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.1. Residential Treatment Centers |
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Outpatient Treatment Centers |
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Inpatient Treatment Centers |
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Market Opportunity Analysis Global Opioids Addiction Prevention Market Forecast, By Route of Administration, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.1. Oral |
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Parental |
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8. Market Opportunity Analysis Global Opioids Addiction Prevention Market Forecast, By Distribution Channel, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.1. Retail Pharmacies |
8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Hospitals |
8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Rehabilitation Centers |
8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9. Global Opioids Addiction Prevention Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Opioids Addiction Prevention Market - Opportunity Analysis Index, By Drug Type, Treatment Centers, Route of Administration, Distribution Channel, and Region, 2022 - 2028 |
10. North America Opioids Addiction Prevention Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
10.1. Drug Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Naloxone |
10.1.2. Buprenorphine |
10.1.3. Methadone |
10.2. Treatment Centers Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Residential Treatment Centers |
10.2.2. Outpatient Treatment Centers |
10.2.3. Inpatient Treatment Centers |
10.3. Route of Administration Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Oral |
10.3.2. Parental |
10.4. Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.4.1. Retail Pharmacies |
10.4.2. Hospitals |
10.4.3. Rehabilitation Centers |
10.5. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. U.S. |
10.5.2. Canada |
10.6. North America Opioids Addiction Prevention Market - Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 - 2028 |
10.7. North America Opioids Addiction Prevention Market Dynamics – Trends |
11. Europe Opioids Addiction Prevention Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
11.1. Drug Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
11.1.1. Naloxone |
11.1.2. Buprenorphine |
11.1.3. Methadone |
11.2. Treatment Centers Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Residential Treatment Centers |
11.2.2. Outpatient Treatment Centers |
11.2.3. Inpatient Treatment Centers |
11.3. Route of Administration Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Oral |
11.3.2. Parental |
11.4. Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Retail Pharmacies |
11.4.2. Hospitals |
11.4.3. Rehabilitation Centers |
11.5. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Italy |
11.5.5. Spain |
11.5.6. Rest of Europe |
11.6. Europe Opioids Addiction Prevention Market - Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 - 2028 |
11.7. Europe Opioids Addiction Prevention Market Dynamics – Trends |
12. Asia-Pacific Opioids Addiction Prevention Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
12.1. Drug Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
12.1.1. Naloxone |
12.1.2. Buprenorphine |
12.1.3. Methadone |
12.2. Treatment Centers Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Residential Treatment Centers |
12.2.2. Outpatient Treatment Centers |
12.2.3. Inpatient Treatment Centers |
12.3. Route of Administration Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Oral |
12.3.2. Parental |
12.4. Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Retail Pharmacies |
12.4.2. Hospitals |
12.4.3. Rehabilitation Centers |
12.5. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Japan |
12.5.2. China |
12.5.3. India |
12.5.4. ASEAN |
12.5.5. Rest of Asia-Pacific |
12.6. Asia-Pacific Opioids Addiction Prevention Market - Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 - 2028 |
12.7. Asia-Pacific Opioids Addiction Prevention Market Dynamics – Trends |
13. Latin America Opioids Addiction Prevention Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
13.1. Drug Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
13.1.1. Naloxone |
13.1.2. Buprenorphine |
13.1.3. Methadone |
13.2. Treatment Centers Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Residential Treatment Centers |
13.2.2. Outpatient Treatment Centers |
13.2.3. Inpatient Treatment Centers |
13.3. Route of Administration Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Oral |
13.3.2. Parental |
13.4. Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Retail Pharmacies |
13.4.2. Hospitals |
13.4.3. Rehabilitation Centers |
13.5. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Argentina |
13.5.3. Rest of Latin America |
13.6. Latin America Opioids Addiction Prevention Market - Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 - 2028 |
13.7. Latin America Opioids Addiction Prevention Market Dynamics – Trends |
14. Middle East and Africa Opioids Addiction Prevention Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
14.1. Drug Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
14.1.1. Naloxone |
14.1.2. Buprenorphine |
14.1.3. Methadone |
14.2. Treatment Centers Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
14.2.1. Residential Treatment Centers |
14.2.2. Outpatient Treatment Centers |
14.2.3. Inpatient Treatment Centers |
14.3. Route of Administration Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Oral |
14.3.2. Parental |
14.4. Distribution Channel Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Retail Pharmacies |
14.4.2. Hospitals |
14.4.3. Rehabilitation Centers |
14.5. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Saudi Arabia |
14.5.2. GCC Countries |
14.5.3. South Africa |
14.5.4. Rest of MEA |
14.6. MEA Opioids Addiction Prevention Market - Opportunity Analysis Index, By Drug Type, Route of Administration and Country, 2022 - 2028 |
14.7. MEA Opioids Addiction Prevention Market Dynamics – Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Drug Type Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Omeros |
15.2.2. Camurus |
15.2.3. Orexo |
15.2.4. MediciNova |
15.2.5. Teva Pharmaceuticals |
15.2.6. Â Hikma Pharmaceuticals |
15.2.7. Reckitt Benckiser Pharmaceuticals, Inc. |
15.2.8. Mylan |
15.2.9. Dr. Reddy's Laboratories |
15.2.10. Addinex Technologies, Inc. |
15.2.11. Indivior |
15.2.12. Alkermes |
15.2.13. Titan Pharmaceuticals |
16. Research Methodology |
17. Key Assumptions and Acronyms |
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.